FDA Draft Guidance on Stem Cells

21. march 2016 at 8:00 | Veronika Valdova, ARETE-ZOE |  Medicine & Pharmacy

Due to considerable interest in the Public Hearing, "Request for Comments - Draft Guidances Relating to the Regulation of Human Cells, Tissues or Cellular or Tissue-Based Products," the FDA intends to extend the comment period and has postponed the hearing. The agency also intends to schedule a scientific workshop to gather information from stakeholders regarding the generation of scientific evidence to facilitate the development of safe and effective cell based therapeutics.

New comment

Log in
  Don't you have your own web yet? Create it for free on Blog.cz.

Actual articles